Skip to main content
Monday, November 16, 2026Nov 16

Drug supply firm execs say they didn’t cause opioids crisis

George Barrett, left, executive chairman of the board, Cardinal Health, Inc., Dr. Joseph Mastandrea, chairman of the board, Miami-Luken, Inc., John Hammergren, chairman, president, and CEO, McKesson Corporation, J. Christopher Smith, former president and CEO, H.D. Smith Wholesale Drug Company, and Steven Collis, chairman, president, and CEO, AmerisourceBergen Corporation, are sworn in before they testify during a hearing of the Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, about the opioid epidemic, on Capitol Hill, Tuesday, May 8, 2018 in Washington. (AP Photo/Alex Brandon)
George Barrett, left, executive chairman of the board, Cardinal Health, Inc., Dr. Joseph Mastandrea, chairman of the board, Miami-Luken, Inc., John Hammergren, chairman, president, and CEO, McKesson Corporation, J. Christopher Smith, former president and CEO, H.D. Smith Wholesale Drug Company, and Steven Collis, chairman, president, and CEO, AmerisourceBergen Corporation, are sworn in before they testify during a hearing of the Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, about the opioid epidemic, on Capitol Hill, Tuesday, May 8, 2018 in Washington. (AP Photo/Alex Brandon)

WASHINGTON – Top executives of the nation’s leading wholesale drug distributors told Congress under oath Tuesday their companies didn’t help cause the nation’s deadly opioid epidemic, drawing bipartisan wrath that included one lawmaker suggesting prison terms for some company officials.

The confrontation came at a House subcommittee hearing at which legislators asked why huge numbers of potentially addictive prescription opioid pills had been shipped to West Virginia, among the states hardest hit by the drug crisis. Lawmakers are making an election-year push for legislation aimed at curbing a growing epidemic that saw nearly 64,000 people die last year from drug overdoses, two-thirds from opioids.

Company officials’ responses ranged from apologies to explanations to finger-pointing at doctors who prescribe the drugs, pharmacies that fill prescriptions and the federal Drug Enforcement Administration for not doing enough as overseer of sales of legally controlled substances.

photo John Hammergren, chairman, president, and CEO, McKesson Corporation, testifies during a hearing of the Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, about combating the opioid epidemic, on Capitol Hill, Tuesday, May 8, 2018 in Washington. (AP Photo/Alex Brandon)

In a scene that recalled Congress’ 1994 grilling of tobacco industry officials, House Energy and Commerce investigations subcommittee Chairman Gregg Harper, R-Miss., administered oaths to the heads of five pharmaceutical distributors and asked each if “the actions you or your company took contributed to the opioid epidemic.”

Answering no were the leaders of the nation’s three biggest distribution firms: McKesson Corp., Cardinal Health Inc. and AmerisourceBergen Corp., which dominate the U.S. market. The only yes came from Joseph Mastandrea, chief of the smaller Miami-Luken Inc., while the former chief of H.D. Smith Wholesale Drug Company also said no.